COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon
Thumbnail

A new warning for heart patients as COVID-19 continues to spread

The British Heart Foundation (BHF) has published a statement warning patients with certain medical conditions, including cardiovascular diseases, to be “extra vigilant” as the new coronavirus continues to spread.

Thumbnail

Patients with COVID-19 should keep taking key CVD medications

Patients with cardiovascular disease should continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) as prescribed if they are diagnosed with the new coronavirus (COVID-19), according to a joint statement from three medical societies. 

Thumbnail

ACC issues COVID-19 guidance for cardiologists

Just days before the American College of Cardiology canceled its annual scientific sessions for the first time in the meeting’s 69-year history, it released a set of guidelines for cardiology care teams dealing with the COVID-19 outbreak.

Thumbnail

Hypertension ‘a key dangerous factor’ in COVID-19 mortality

Hypertensive patients may be at a greater risk of dying from COVID-19, the viral disease stemming from the world’s largest coronavirus outbreak to date, according to Bloomberg News.

Thumbnail

ACC.20/WCC canceled amid COVID-19 outbreak

ACC.20/WCC, the joint meeting of the American College of Cardiology and World Congress of Cardiology set for March 28-30 in Chicago, has been cancelled amid worries about the COVID-19 outbreak.

Thumbnail

ACC, ATA push for expanded use of telehealth to fight COVID-19

The American College of Cardiology, American College of Physicians and other industry groups are pushing for the expanded use of telehealth in combating the new coronavirus, or COVID-19.

Displaying 425 - 430 of 430

Around the web

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.